5 Medicare Changes Every Enrollee Should Know About in 2026

For 2026 Medicare costs are increasing: the standard Part B premium rises to $202.90 (up $17.90 from $185 in 2025) and the Part B deductible to $283 (up $26 from $257). Part A inpatient deductible increases to $1,736 (from $1,676), the daily coinsurance for hospital days 61–90 rises to $434 (from $419), and lifetime reserve day coinsurance to $868 (from $838); IRMAA surcharges will apply to singles above $109,000 and joint filers above $218,000. These adjustments will erode the 2.8% Social Security COLA, reduce retirees' disposable income, and carry modest implications for Medicare Advantage/insurer pricing and senior consumer spending.

Analysis

Market structure: The 2026 Medicare cost increases (Part B premium +$17.90 to $202.90, deductible +$26, Part A inpatient deductible +$60) mechanically shift ~32% of the average 2.8% Social Security COLA ($56) back to health spending, tightening disposable income for seniors. Winners: Medicare Advantage insurers (UnitedHealth UNH, Humana HUM, Elevance ELV, CVS/Caremark CVS) can reprice plans, grow MA enrollment, and capture risk-adjusted payments; losers: hospitals, skilled-nursing and senior-housing operators face higher uncompensated care and lower private-pay demand. IRMAA thresholds ($109k/$218k) keep higher-income exposure limited (~8% affected), so concentrated effects mostly hit lower-middle retirees.

Risk assessment: Tail risks include a political backlash leading to abrupt reimbursement cuts or capitation changes (legislative action within 3–12 months) and CMS rule changes that could reverse MA pricing benefits; another tail is a sharper-than-expected rise in long-term yields if Medicare spending materially widens deficits. Short-term (days–weeks) volatility will hinge on CMS notices and SSA COLA publication; medium-term (3–12 months) effects depend on enrollment shifts to MA and Part D formulary reforms. Hidden dependency: provider margin pressure depends on state Medicaid backstops and hospital negotiation leverage with MA plans.

Trade implications: Tilt portfolios toward large-cap diversified insurers with MA exposure (UNH, HUM, ELV) via 3–5% net long exposure funded by trimming 1–3% from healthcare real-estate (WELL, VTR) and elective-care names; pair trade: long UNH/ELV vs short WELL/VTR. Options: buy 6–9 month call spreads on UNH/HUM (0.5–1% NAV) and symmetrical put spreads on WELL/VTR to limit capital while capturing asymmetric downside. Enter within 2–8 weeks ahead of CMS rate notices; reassess at 90–180 days when enrollment and rate guidance are updated.

Contrarian angles: The market underestimates that MA plans can accelerate price pass-through and network steering, so insurer upside may be underpriced—especially for UNH which has diversified revenue streams beyond MA. Conversely, consensus may over-penalize senior housing REITs based only on near-term affordability; demographic tailwinds (aging population) cap long-term downside, so shorts should be size-limited and hedged. Historical parallel: 2010–2014 MA expansion created multi-year outperformance for large insurers despite episodic political noise, suggesting patience (6–24 months) for the thesis to play out.

Key Decisions for Investors

• Establish a 3% portfolio long position split 60/40 between UnitedHealth (UNH) and Elevance (ELV) over the next 2–6 weeks; prefer 6–9 month call spreads (cost-limited) if seeking leverage—target 15–30% upside over 6–12 months and size to 0.5–1% NAV per options position.
• Initiate a 1.5–2% short exposure to senior-housing/healthcare REITs (Welltower WELL, Ventas VTR) via 3–6 month put spreads or borrow/short equity, with stop-loss at 10% adverse move and a profit target of 20–35% within 3–12 months.
• Execute a pair trade: long UNH (1.5%) and short WELL (1.0%) to capture relative upside from MA repricing and downside from private-pay stress; rebalance after CMS Advance Notice or within 90 days.
• Trim 1–2% duration from core bond holdings (reduce TLT/long-duration Treasuries) and redeploy into short-duration investment-grade corporates or 2–5 year TIPS to hedge potential deficit-driven yield pressure within next 30–60 days.
• Monitor two binary catalysts in the next 30–90 days: CMS Medicare Advantage/Part B rate notices and the CBO estimate of Medicare outlays; if CMS signals MA payment cuts >1% or CBO revises 10-year Medicare costs materially higher, tighten risk controls and increase hedges on insurer longs.